论文部分内容阅读
目的:对嗜铬细胞瘤/副神经节瘤患者手术前后血糖变化进行研究分析,探讨嗜铬细胞瘤/副神经节瘤与患者高血糖之间的关系,促进围手术期安全。方法:对2014年1月~2015年12月我院收治的136例嗜铬细胞瘤/副神经节瘤患者做回顾性分析,全部患者均通过定性及定位检查,诊断嗜铬细胞瘤或副神经节瘤明确,16例患者因各种原因未接受手术治疗,120例接受手术的患者术后病理证实为嗜铬细胞瘤或副神经节瘤。结果:120例患者中65例诊断为继发性高血糖,其中糖尿病者25例,糖耐量减低者40例;65例患者中59例术后血糖不同程度下降,其中45例降至正常。结论:继发性血糖升高在嗜铬细胞瘤或副神经节瘤患者中常见,手术治疗后绝大多数患者血糖显著下降,积极的手术治疗有助于此类患者血糖恢复正常。
Objective: To study the changes of blood glucose in patients with pheochromocytoma / paraganglioma before and after operation to investigate the relationship between pheochromocytoma / paraganglioma and hyperglycemia in patients and promote perioperative safety. Methods: A retrospective analysis was performed on 136 patients with pheochromocytoma / paraganglioma treated in our hospital from January 2014 to December 2015. All patients were diagnosed with pheochromocytoma or paraganglioma by qualitative and positional examination Knot tumor clear, 16 patients were not undergoing surgical treatment for various reasons, 120 patients undergoing surgery after pathology confirmed as pheochromocytoma or paraganglioma. Results: Of 120 patients, 65 cases were diagnosed as secondary hyperglycemia, including 25 cases of diabetes mellitus and 40 cases of impaired glucose tolerance. Among the 65 cases, 59 cases of postoperative blood glucose decreased to varying degrees, of which 45 cases dropped to normal. CONCLUSIONS: Secondary hyperglycemia is common in patients with pheochromocytoma or paraganglioma. After the operation, the blood glucose of the overwhelming majority of patients is significantly decreased. Positive surgical treatment can help normal blood glucose recovery of these patients.